2002
DOI: 10.1006/viro.2002.1359
|View full text |Cite
|
Sign up to set email alerts
|

Human Adenoviruses of Subgenera B, C, and E with Various Tropisms Differ in Both Binding to and Replication in the Epithelial A549 and 293 Cells

Abstract: Adenoviruses of six subgenera, namely, adenovirus 31 (Ad31) (subgenus A), Ad3, Ad7, Ad11p, Ad11a, and Ad35 (subgenus B), Ad5v and Ad5p (subgenus C), Ad37 (subgenus D), Ad4 (subgenus E), and Ad41 (subgenus F), were studied. The relative binding properties of different adenoviruses to 293 (human kidney embryonic cells) and A549 (human lung carcinoma cells) cells were compared by flow cytometry. All analyzed adenoviruses bound to cells in a dose-dependent manner. The binding capacity showed that Ad11p, Ad35 (subg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

3
30
0
1

Year Published

2003
2003
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(34 citation statements)
references
References 55 publications
3
30
0
1
Order By: Relevance
“…The main disadvantages with Ad5-based vectors appear to be low transduction of target cells and high preexisting immunity (2,13,20,24,34,48,68,74). In several cases, species B:2 adenoviruses have been shown to attach to host cells and deliver genes much more efficiently than other adenoviruses, including Ad5 (43,44,50,57,62). Thus, we believe that the identification of CD46 as a cellular receptor for these adenoviruses widens the understanding of adenovirus tropism and may also contribute to development of more effective adenovirus-based gene therapy vectors.…”
Section: Discussionmentioning
confidence: 99%
“…The main disadvantages with Ad5-based vectors appear to be low transduction of target cells and high preexisting immunity (2,13,20,24,34,48,68,74). In several cases, species B:2 adenoviruses have been shown to attach to host cells and deliver genes much more efficiently than other adenoviruses, including Ad5 (43,44,50,57,62). Thus, we believe that the identification of CD46 as a cellular receptor for these adenoviruses widens the understanding of adenovirus tropism and may also contribute to development of more effective adenovirus-based gene therapy vectors.…”
Section: Discussionmentioning
confidence: 99%
“…However, we have clearly demonstrated that the F7 vector has a dramatic effect on Ad5 vector detargeting, which substantiates its use as a platform for retargeting (in place of a mutated CAR binding fiber). Subgroup B viruses have been shown to have distinct cell targets, as previously described (20,(23)(24)(25)33), and it will be important to identify the receptor used by the subgroup B viruses as well as the functional ligand domain present in the F7 homotrimer. The extension of the non-CAR binding vectors to the F7F41S tandem platform represents a novel class of modified Ad5-based vectors that provides distinct advantages over traditional single-fiber swap chimeras.…”
Section: Discussionmentioning
confidence: 99%
“…A CAR binding serotype can be converted to a subgroup B receptor-targeted vector simply by genetically switching the fiber terminal exons (12). Subgroup B viruses can bind to many of the same cell types as CAR binding viruses, but there are also cell types that demonstrate differential affinity for the subgroup B fiber versus the CAR binding serotypes (20,(23)(24)(25)33). Another distinct class of fiber-containing adenoviruses is the enteric subgroup F viruses (serotypes 40 and 41).…”
mentioning
confidence: 99%
“…(i) Several groups found that Ad3 and Ad7 do not use CD46 for infection (7, 21), (ii) Ad3 and Ad7 (group B1) and Ad35 (group B2) do not compete for binding on HeLa cells (31,35), and (iii) Ad11p fiber knob can completely block binding of wild-type Ad35 to A549 cells, while recombinant Ad35 fiber knob cannot completely block Ad11p binding (22,41). While these data suggest that Ad3 and Ad7 and probably Ad11 can use a receptor that is different from CD46, the nature of this receptor(s) remains elusive.…”
mentioning
confidence: 99%